Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jul 10:7:12.
doi: 10.1186/1471-2393-7-12.

Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT

Kim E Boers  1 , Denise Bijlenga, Ben W J Mol, Saskia LeCessie, Erwin Birnie, Marielle G van Pampus, Rob H Stigter, Kitty W M Bloemenkamp, Claudia A van Meir, Joris A M van der Post, Dick J Bekedam, Lucy S M Ribbert, Addie P Drogtrop, Paulien C M van der Salm, Anjoke J M Huisjes, Christine Willekes, Frans J M E Roumen, Hubertina C J Scheepers, Karin de Boer, Johannes J Duvekot, Jim G Thornton, Sicco A Scherjon
Affiliations
Randomized Controlled Trial

Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT

Kim E Boers et al. BMC Pregnancy Childbirth. .

Abstract

Background: Around 80% of intrauterine growth restricted (IUGR) infants are born at term. They have an increase in perinatal mortality and morbidity including behavioral problems, minor developmental delay and spastic cerebral palsy. Management is controversial, in particular the decision whether to induce labour or await spontaneous delivery with strict fetal and maternal surveillance. We propose a randomised trial to compare effectiveness, costs and maternal quality of life for induction of labour versus expectant management in women with a suspected IUGR fetus at term.

Methods/design: The proposed trial is a multi-centre randomised study in pregnant women who are suspected on clinical grounds of having an IUGR child at a gestational age between 36+0 and 41+0 weeks. After informed consent women will be randomly allocated to either induction of labour or expectant management with maternal and fetal monitoring. Randomisation will be web-based. The primary outcome measure will be a composite neonatal morbidity and mortality. Secondary outcomes will be severe maternal morbidity, maternal quality of life and costs. Moreover, we aim to assess neurodevelopmental and neurobehavioral outcome at two years as assessed by a postal enquiry (Child Behavioral Check List-CBCL and Ages and Stages Questionnaire-ASQ). Analysis will be by intention to treat. Quality of life analysis and a preference study will also be performed in the same study population. Health technology assessment with an economic analysis is part of this so called Digitat trial (Disproportionate Intrauterine Growth Intervention Trial At Term). The study aims to include 325 patients per arm.

Discussion: This trial will provide evidence for which strategy is superior in terms of neonatal and maternal morbidity and mortality, costs and maternal quality of life aspects. This will be the first randomised trial for IUGR at term.

Trial registration: Dutch Trial Register and ISRCTN-Register: ISRCTN10363217.

PubMed Disclaimer

References

    1. Clausson B, Cnattingius S, Axelsson O. Preterm and term births of small for gestation age infants: population-based study of risk factors among nulliparous women. Br J Obstet Gynecol. 1998;105:1011–17. - PubMed
    1. Balcazar H, Keefer L, Chard T. Use of anthropometric indicators and maternal risk factors to evaluate intrauterine growth retardation in infants weighing more than 2500 grams at birth. Early Hum Dev. 1994;36:147–55. doi: 10.1016/0378-3782(94)90001-9. - DOI - PubMed
    1. Chang TC, Robson SC, Spencer JAD, Gallivan S. Prediction of perinatal mortality at term in small fetuses: comparison of foetal growth and Doppler ultrasound. Br J Obstet Gynaecol. 1994;101:422–7. - PubMed
    1. Boulet SL, Alexander GR, Salihu HM, Kirby RS, Carlo WA. Fetal growth risk curves: defining levels of fetal growth restriction by neonatal death risk. Am J Obstet Gynecol. 2006;195:1571–7. doi: 10.1016/j.ajog.2006.03.069. - DOI - PubMed
    1. Dijxhoorn MJ, Visser GHA, Touwen BCL, Huisjes HJ. Apgar score, meconium and acidaemia at birth in smallforgestational age infants born at term, and their relation to neonatal neurological morbidity. Br J Obstet Gynaecol. 1987;94:873–9. - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources